Drug modulation of stress reactions
Topics:
(**)
Italian translation provided / con traduzione in italiano
* The
special role of glutamine as antistress agent and cell-mediated immunity fuel.(**)
*Prolonged comas and stress: Possible drug therapy? (**)
*Tuberous sclerosis, in a child with epilepsy, autism and mental
retardation; Report of the rehabilitative and drug therapy intervention (**)
*Drug therapy of bruxism as modulation of stress answers (**)
* Drug
therapy of bruxism in Down children. A preliminary report.(**)
*The
rationale for drug therapy in children with upper respiratory tract infections
easiness induced by stress (**)
*
Drug therapy of upper respiratory tract infections easiness in Downs: A survey
on 328 persons (**)
*Unwanted
effects of drugs and premenstrual syndrome
*
Drug therapy of pseudodementia as modulation of stress reactions. Three cases (**)
*
The use of drugs to modulate stress responses reduces the time of intensive
care needed by Down children to recover after open-heart surgery (**)
* The
anticipation of walking in drug treated Down infants: A controlled study (**)
*Drug therapy of squint in Down syndrome subjects. Result according to
the length of drugs taking: Report on 125 cases (**)
*Toilet
habits in drug treated Downs: A survey on 209 subjects (**)
*
Antistress and cell-mediated immuno-therapy in HIV+ persons (**)
* Opposite half-brain dominance of specific functions? Another case in a
Down child under drug therapy. (**)
*
Glutamine as the key amino acid in promoting cell-mediated immunity: 20 years of clinical experience (**)
* Food habits in drug treated Downs of 10 years or more (**)
* Penises more normally sized and erection in 56 Down children undergoing
drug therapy (**)
* Drug therapies for sleep troubles, iperactivity and aggression in young
adult autistics (**)
*Drug therapy in Down's syndrome: A theoretical context (**)
* Depression
in Down children: Clinical and therapeutical report on 45 cases (**)
*Study on bike riding in Downs aged 10 or more and treated by drug
therapy (**)
*Drug therapies of bruxism in Down children:
Preliminary report (**)
*S-adenosil-l-methionine
(SAMe) decreases articular laxity in Down children? Preliminary report (**)
*Problems of attention and concentration leading to interruption of
studying by high school and University students: A report of 4 cases. (**)
* First months of drug therapy in a Cri-du-chat case (**)
* Drug therapy in a girl aged ten with Smith-Magenis syndrome. (Updated September 2003)(**)
*Mitigation of facial features in Downs undergoing drug therapy: 23 years
later. (**)
*The modulation of stress answers in patients with cancers (**)
* Possibilities and limits of drug therapies in dementias (**)
* Drug therapy in Aicardi-Goutieres syndrome: Report of a 61-months
folloup (last updating: October 2004) (**)
*The
pharmacological approach to treating childhood psychoses: Theoretical bases
(**)
*Childhood psychoses: Results of drug treatment with Down and non-Down
subjects(**)
*Plasma
amino acids in an autistic girl, first and after 7 years of pharmocotherapy
(**)
*Antidepressant
and immune modulator activity of l-glutamine (**)
* An
anosmia-hyperosmia case with hypogeusia, from probable stress, Improved
following an antistress drug therapy.
(**)
* Childhood psychoses: Results on the school achievement of Down
and non-Down subjects(**)
* A case of dyslexia in a school age boy: a trial with
drugs for 44 months (**)
* Fifteen months of palliative theraapy, even with
manganese sulfate, in two siblings with neural-axonal dystrophy of
Hallervorden-Spatz (**)
*The case history of a 32-years-old woman with
premenstrual syndrome by now rebellious to usual therapies improved with
antistress drugs (Updating November 2003) (**)
* Childhood psychoses: Results of drug
treatment on social behaviour in Down and non-Down subjects (**)
* The
case history of a 32-years-old woman with premenstrual syndrome by now
rebellious to usual therapies improved with antistress drugs (Updated on
January 2005 )(**)
*Childhood psychoses: Results of drug
treatment on language development in Down and non-Down subjects (**)
* Twenty-seven months of antistress drug therapy in a girl
with partial trisomy 22 (**)
* Treatment
with antistress drugs of a GM1 gangliosidosis, of probable intermediate
juvenile-adult type. (updated, April 2004 (**)
* A floppy child with
polymicrogiria and mental retardation. Report of the first nine months of drug treatment . (Upadating
September 2003) (**)
* Seventeen
months of drug therapy in a child with ligamentous laxity and clumsiness. Updating October2003 (**)
The balance
in 230 Down subjects. An evaluation after one-year antistress drug therapies. (**)
* A third case
of anosmia-hyperosmia with ageusia, following stress and possible viral
infection, improved with an antistress drug therapy.
(Updated June 2005)
(**)
* Drooling (or
sialorrhea) in Downs treated with primarily antistress drugs. (**).
* A
third case of atypical depression, with tinnitus, in a 38-years-old woman. Its
improvement with antistress drug therapy (updated on January 2005) (**)
* Hyperosmia, and headache's fits from heavy, olfactory stimuli in a 35-years-old man. An approach with antiepilectic and antistress drugs.
(**)
* Motor improvements after 3-8
months of drug treatment in the Down. (**)
* Workshop on Drug Therapy in Mental
Retardation